$1.70
0.010.59%
Pre-Market: Apr 4, 7:51 PM EDT
Comments
Loading...
Annexon Insider Trading Activity | NASDAQ:ANNX | Benzinga
Track the latest Annexon insider trading activity. Stay informed on recent buys, sells, and market impact for Annexon stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Annexon Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 18, 2025, Michael Overdorf, the company's EVP & CHIEF BUSINESS OFFICER sold 1.43K shares for $2.99 each.
- On February 18, 2025, Jennifer Lew, the company's EVP & CHIEF FINANCIAL OFFICER sold 1.79K shares for $2.98 each.
- On February 18, 2025, Ted Yednock, the company's EVP & CHIEF INNOVATION OFFICER sold 1.78K shares for $2.99 each.
Ownership Statistics for Annexon Inc
Shares Outstanding
109.710M
Insider Shares Owned
974.536K
Insider Percentage Owned
0.91%
Institutional Shares Held
57.127M
Institutional Percentage Held
52.1%
| Feb 20, 2025 | Jamie Dananberg | CHIEF MEDICAL OFFICER | -5.52K | $2.96 | -$16.34K | SELL | -14.16% | 33.48K | Feb 18 | View |
| Feb 20, 2025 | RICHARD DEAN ARTIS | EVP & CHIEF SCIENTIFIC OFFICER | -5.51K | $2.97 | -$16.38K | SELL | -6.17% | 83.81K | Feb 18 | View |
| Feb 20, 2025 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -8.35K | $2.91 | -$24.28K | SELL | -11.99% | 61.24K | Feb 18 | View |
| Feb 20, 2025 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -6.62K | $2.95 | -$19.52K | SELL | -7.10% | 86.58K | Feb 18 | View |
| Feb 20, 2025 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -6.91K | $2.92 | -$20.18K | SELL | -8.16% | 77.77K | Feb 18 | View |
| Feb 18, 2025 | Douglas Love | PRESIDENT AND CEO | -5.02K | $2.95 | -$14.81K | SELL | -1.41% | 351.55K | Feb 13 | View |
| Feb 18, 2025 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -1.79K | $2.98 | -$5.32K | SELL | -2.07% | 84.68K | Feb 13 | View |
| Feb 18, 2025 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -1.43K | $2.99 | -$4.26K | SELL | -1.51% | 93.20K | Feb 13 | View |
| Feb 18, 2025 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -1.78K | $2.99 | -$5.33K | SELL | -2.50% | 69.58K | Feb 13 | View |
| Dec 04, 2024 | William Carson | — | 3.20K | $5.33 | $17.06K | BUY | 14.29% | 25.60K | Dec 02 | View |
| Oct 17, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 0.00 | $4.63 | -$30.07K | SELL-OPTIONS | 0.00% | 71.36K | Oct 15 | View |
| Oct 02, 2024 | William Carson | — | 3.20K | $5.97 | $19.10K | BUY | 16.67% | 22.40K | Oct 01 | View |
| Sep 20, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -4.50K | $7.10 | -$31.95K | SELL | -5.93% | 71.36K | Sep 19 | View |
| Sep 16, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -5.50K | $6.16 | -$33.88K | SELL | -6.76% | 75.86K | Sep 12 | View |
| Sep 06, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -5.50K | $5.64 | -$31.02K | SELL | -6.33% | 81.36K | Sep 05 | View |
| Sep 04, 2024 | William Carson | — | 3.20K | $5.48 | $17.54K | BUY | 20.00% | 19.20K | Sep 03 | View |
| Aug 30, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -5.50K | $5.95 | -$32.73K | SELL | -5.95% | 86.86K | Aug 29 | View |
| Aug 05, 2024 | William Carson | — | 3.20K | $6.24 | $19.97K | BUY | 25.00% | 16.00K | Aug 01 | View |
| Jul 17, 2024 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -784.00 | $6.02 | -$4.72K | SELL | -0.82% | 94.62K | Jul 15 | View |
| Jul 17, 2024 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -1.10K | $6.03 | -$6.66K | SELL | -1.26% | 86.47K | Jul 15 | View |
| Jul 17, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -1.11K | $6.02 | -$6.66K | SELL | -1.18% | 92.36K | Jul 15 | View |
| Jul 02, 2024 | William Carson | — | 3.20K | $5.00 | $16.00K | BUY | 33.33% | 12.80K | Jul 01 | View |
| Jun 05, 2024 | William Carson | — | 3.20K | $4.83 | $15.46K | BUY | 50.00% | 9.60K | Jun 03 | View |
| May 03, 2024 | William Carson | — | 3.20K | $4.68 | $14.98K | BUY | 100.00% | 6.40K | May 01 | View |
| Apr 10, 2024 | William Carson | — | 3.20K | $6.07 | $19.41K | BUY | ∞ | 3.20K | Apr 08 | View |
| Feb 21, 2024 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 36.41K | $5.53 | -$14.34K | GRANT | 79.75% | 82.06K | Feb 16 - Feb 20 | View |
| Feb 21, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 36.40K | $5.51 | -$14.35K | GRANT | 63.77% | 93.47K | Feb 16 - Feb 20 | View |
| Feb 21, 2024 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | 37.05K | $5.48 | -$10.69K | GRANT | 76.25% | 85.64K | Feb 16 - Feb 20 | View |
| Feb 14, 2024 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -1.35K | $5.53 | -$7.46K | SELL | -2.70% | 48.59K | Feb 12 | View |
| Feb 14, 2024 | Douglas Love | PRESIDENT AND CEO | -5.78K | $5.54 | -$32.03K | SELL | -2.86% | 196.12K | Feb 12 | View |
| Feb 14, 2024 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -1.81K | $5.54 | -$10.02K | SELL | -3.81% | 45.65K | Feb 12 | View |
| Feb 14, 2024 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | -1.81K | $5.54 | -$10.03K | SELL | -3.07% | 57.08K | Feb 12 | View |
| Jan 23, 2024 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -978.00 | $3.84 | -$3.75K | SELL | -2.09% | 45.80K | Jul 11 | View |
| Jan 23, 2024 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -1.06K | $3.84 | -$4.05K | SELL | -2.18% | 47.46K | Jul 11 | View |
| Dec 29, 2023 | Ted Yednock | EVP & CHIEF INNOVATION OFFICER | 0.00 | $3.07 | -$60.79K | SELL-OPTIONS | 0.00% | 0.00 | Dec 27 | View |
| Dec 28, 2023 | Muneer A Satter | DIRECTOR | 350.00K | $2.88 | $1.01M | BUY | 4.96% | 7.41M | Dec 26 | View |
| May 30, 2023 | Bain Capital Life Sciences Investors LLCBain Capital Life Sciences Fund LPBain Capital Life Sciences Partners LPBCIP Life Sciences Associates LP | 10% OWNER | 300.00K | $2.13 | $639.72K | BUY | 5.55% | 5.70M | May 25 | View |
| Feb 17, 2023 | Douglas Love | PRESIDENT & CEO | -6.57K | $5.87 | -$38.56K | SELL | -3.22% | 197.65K | Feb 15 | View |
| Feb 15, 2023 | Michael Overdorf | EVP & CHIEF BUSINESS OFFICER | -1.65K | $6.30 | -$10.37K | SELL | -5.59% | 27.80K | Feb 13 - Feb 14 | View |
| Feb 15, 2023 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | -1.91K | $6.31 | -$12.04K | SELL | -6.07% | 29.54K | Feb 13 - Feb 14 | View |
| Feb 14, 2023 | Muneer A Satter | DIRECTOR | 2.65M | $6.80 | $18.00M | BUY | 60.04% | 7.06M | Feb 10 | View |
| Jul 11, 2022 | Muneer A Satter | DIRECTOR | 2.45M | $3.84 | $9.42M | BUY | 125.53% | 4.41M | Jul 07 | View |
| Apr 18, 2022 | Douglas Love | PRESIDENT & CEO | 60.00K | $2.45 | $146.81K | BUY | 42.57% | 200.94K | Apr 14 | View |
| Sep 20, 2021 | Douglas Love | PRESIDENT & CEO | 0.00 | $11.73 | -$154.77K | SELL-OPTIONS | 0.00% | 0.00 | Sep 16 | View |
| Sep 15, 2021 | Ted Yednock | EVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $10.84 | -$296.64K | SELL-OPTIONS | 0.00% | 0.00 | Sep 13 | View |
| Sep 15, 2021 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $13.75 | -$43.82K | SELL-OPTIONS | 0.00% | 2.00K | Sep 13 | View |
| Jun 09, 2021 | Douglas Love | PRESIDENT & CEO | 0.00 | $11.92 | -$157.66K | SELL-OPTIONS | 0.00% | 0.00 | Jun 07 - Jun 08 | View |
| Jun 07, 2021 | Ted Yednock | EVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $11.45 | -$301.18K | SELL-OPTIONS | 0.00% | 0.00 | Jun 03 | View |
| Jun 01, 2021 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $14.86 | -$51.63K | SELL-OPTIONS | 0.00% | 2.00K | May 27 | View |
| Apr 02, 2021 | Douglas Love | PRESIDENT & CEO | 0.00 | $14.76 | -$202.95K | SELL-OPTIONS | 0.00% | 0.00 | Mar 31 - Apr 01 | View |
| Mar 31, 2021 | Douglas Love | PRESIDENT & CEO | 0.00 | $13.19 | -$176.73K | SELL-OPTIONS | 0.00% | 0.00 | Mar 29 - Mar 30 | View |
| Mar 29, 2021 | Ted Yednock | EVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $15.24 | -$438.62K | SELL-OPTIONS | 0.00% | 0.00 | Mar 25 | View |
| Mar 26, 2021 | Sanjay Keswani | EVP & CHIEF MEDICAL OFFICER | 0.00 | $18.83 | -$90.60K | SELL-OPTIONS | 0.00% | 0.00 | Mar 24 | View |
| Mar 25, 2021 | Jennifer Lew | EVP & CHIEF FINANCIAL OFFICER | 0.00 | $17.96 | -$104.73K | SELL-OPTIONS | 0.00% | 2.00K | Mar 23 | View |
| Jul 30, 2020 | Clarus Lifesciences III LPClarus Ventures III GP LPBlackstone Clarus III LLCBlackstone Holdings II LPBlackstone Holdings III GP LLCBlackstone Group IncBlackstone Group Management LLCSTEPHEN SCHWARZMAN | — | 2.73M | $17.00 | $3.40M | DERIVATIVE CONVERSION | ∞ | 2.73M | Jul 28 | View |
| Jul 28, 2020 | Bain Capital Life Sciences Investors LLCBain Capital Life Sciences Fund LPBCIP Life Sciences Associates LPAdam KoppelBain Capital Life Sciences Partners LPLawrence Jeffrey Schwartz | — | 3.24M | $17.00 | $6.80M | DERIVATIVE CONVERSION | ∞ | 3.24M | Jul 28 | View |
| Jul 28, 2020 | Jennifer Lew | — | 2.00K | $17.00 | $34.00K | PURCHASE | ∞ | 2.00K | Jul 28 | View |
| Jul 28, 2020 | Muneer A Satter | — | 1.95M | $17.00 | $3.40M | DERIVATIVE CONVERSION | ∞ | 1.95M | Jul 28 | View |
| Jul 28, 2020 | James FlynnDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Mgmt LPDEERFIELD PARTNERS LP | — | 1.62M | $17.00 | $11.90M | DERIVATIVE CONVERSION | ∞ | 808.91K | Jul 28 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.